101 related articles for article (PubMed ID: 6595181)
1. Structure-activity studies on synthetic analogues (indolactams) of the tumor promoter teleocidin.
Fujiki H; Suganuma M; Nakayasu M; Tahira T; Endo Y; Shudo K; Sugimura T
Gan; 1984 Oct; 75(10):866-70. PubMed ID: 6595181
[TBL] [Abstract][Full Text] [Related]
2. Synthetic analogues (indolactams) of (-)-indolactam-V are new congeners of the teleocidin class of tumor promoters.
Hirota M; Suganuma M; Yoshizawa S; Horiuchi T; Nakayasu M; Hasegawa M; Endo Y; Shudo K; Fujiki H
Jpn J Cancer Res; 1987 Jun; 78(6):577-82. PubMed ID: 3112073
[TBL] [Abstract][Full Text] [Related]
3. Studies on olivoretins indicate a requirement for a free hydroxyl group for teleocidin B activity.
Horiuchi T; Fujiki H; Suganuma M; Hakii H; Nakayasu M; Hitotsuyanagi Y; Aimi N; Sakai S; Endo Y; Shudo K
Gan; 1984 Oct; 75(10):837-40. PubMed ID: 6439591
[TBL] [Abstract][Full Text] [Related]
4. Pendolmycin, a new tumor promoter of the teleocidin A class on skin of CD-1 mice.
Nishiwaki S; Fujiki H; Yoshizawa S; Suganuma M; Furuya-Suguri H; Okabe S; Nakayasu M; Okabe K; Muratake H; Natsume M
Jpn J Cancer Res; 1991 Jul; 82(7):779-83. PubMed ID: 1908844
[TBL] [Abstract][Full Text] [Related]
5. Quantitative structure-activity studies on indole alkaloid tumor promoter indolactam congeners.
Irie K; Okuno S; Kajiyama S; Koshimizu K; Nishino H; Iwashima A
Carcinogenesis; 1991 Oct; 12(10):1883-6. PubMed ID: 1934269
[TBL] [Abstract][Full Text] [Related]
6. Structure-activity studies of the indole alkaloid tumor promoter teleocidins.
Irie K; Hagiwara N; Tokuda H; Koshimizu K
Carcinogenesis; 1987 Apr; 8(4):547-52. PubMed ID: 3103947
[TBL] [Abstract][Full Text] [Related]
7. A possible naturally occurring tumor promoter, teleocidin B from Streptomyces.
Fujiki H; Mori M; Nakayasu M; Terada M; Sugimura T
Biochem Biophys Res Commun; 1979 Oct; 90(3):976-83. PubMed ID: 292437
[No Abstract] [Full Text] [Related]
8. Twist form of teleocidin derivatives is active in in vivo tumor promotion by (-)-benzolactam-V8-310.
Okabe S; Sueoka N; Komori A; Suganuma M; Endo Y; Shudo K; Fujiki H
Biol Pharm Bull; 1998 May; 21(5):465-8. PubMed ID: 9635501
[TBL] [Abstract][Full Text] [Related]
9. Estimation of tumor promoting activity and structure-function relationships of aplysiatoxins.
Suganuma M; Fujiki H; Tahira T; Cheuk C; Moore RE; Sugimura T
Carcinogenesis; 1984 Mar; 5(3):315-8. PubMed ID: 6323046
[TBL] [Abstract][Full Text] [Related]
10. Nakahara memorial lecture. New classes of tumor promoters: teleocidin, aplysiatoxin, and palytoxin.
Fujiki H; Suganuma M; Tahira T; Yoshioka A; Nakayasu M; Endo Y; Shudo K; Takayama S; Moore RE; Sugimura T
Princess Takamatsu Symp; 1983; 14():37-45. PubMed ID: 6151565
[TBL] [Abstract][Full Text] [Related]
11. Effects of synthetic analogues of teleocidin, indolactam-V, on the differentiation of murine pre-adipose cells.
Sato M; Hiragun A; Shudo K
Cancer Lett; 1985 Jan; 25(3):261-9. PubMed ID: 3918784
[TBL] [Abstract][Full Text] [Related]
12. Similarity of teleocidin B and phorbol ester tumour promoters in effects on membrane receptors.
Umezawa K; Weinstein IB; Horowitz A; Fujiki H; Matsushima T; Sugimura T
Nature; 1981 Apr; 290(5805):411-3. PubMed ID: 6261139
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological activities of (-)-6-n-octyl-indolactam-V, a new potent analogue of the tumor promoter (-)-indolactam-V.
Nakagawa Y; Irie K; Nakamura Y; Ohigashi H; Hayashi H
Biosci Biotechnol Biochem; 1998 Aug; 62(8):1568-73. PubMed ID: 9757563
[TBL] [Abstract][Full Text] [Related]
14. Absence of synergistic effects on tumor promotion in CD-1 mouse skin by simultaneous applications of two different types of tumor promoters, okadaic acid and teleocidin.
Suganuma M; Yatsunami J; Yoshizawa S; Okabe S; Fujiki H
Cancer Res; 1993 Mar; 53(5):1012-6. PubMed ID: 8439947
[TBL] [Abstract][Full Text] [Related]
15. Structure-activity relationship in the induction of Epstein-Barr virus by teleocidin derivatives.
Irie K; Tokuda H; Hagiwara N; Koshimizu K; Hayashi H; Murao S; Ito Y
Int J Cancer; 1985 Oct; 36(4):485-8. PubMed ID: 2995261
[TBL] [Abstract][Full Text] [Related]
16. Comparative effects of aplysiatoxin, debromoaplysiatoxin, and teleocidin on receptor binding and phospholipid metabolism.
Horowitz AD; Fujiki H; Weinstein IB; Jeffrey A; Okin E; Moore RE; Sugimura T
Cancer Res; 1983 Apr; 43(4):1529-35. PubMed ID: 6299522
[TBL] [Abstract][Full Text] [Related]
17. Structure-activity studies of aplysiatoxin-type tumor promoters.
Moore RE
Princess Takamatsu Symp; 1983; 14():49-57. PubMed ID: 6243065
[TBL] [Abstract][Full Text] [Related]
18. Biological activities and cellular uptake studies of fluorescent derivatives of indole alkaloid tumor promoter teleocidin.
Irie K; Okuno S; Koshimizu K; Tokuda H; Nishino H; Iwashima A
Int J Cancer; 1989 Mar; 43(3):513-9. PubMed ID: 2538401
[TBL] [Abstract][Full Text] [Related]
19. Specific binding, stimulation of rodent urinary bladder epithelial ornithine decarboxylase, and induction of transitional cell hyperplasia by the skin tumor promoter 12-O-tetradecanoylphorbol-13-acetate.
Verma AK; Ertürk E; Bryan GT
Cancer Res; 1983 Dec; 43(12 Pt 1):5964-71. PubMed ID: 6315223
[TBL] [Abstract][Full Text] [Related]
20. Modulation of phorbol ester receptors in mouse skin by application of quercetin.
Horiuchi T; Fujiki H; Hakii H; Suganuma M; Yamashita K; Sugimura T
Jpn J Cancer Res; 1986 Jun; 77(6):526-31. PubMed ID: 3089985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
